Company intelligence / Profile preview

Coalesenz

Boston, Massachusetts, United Statescoalesenz.com ↗

Ownership: Private
Development stage: Commercial

Overview

Coalesenz has developed the iCoagLab platform, a patented hand-held diagnostic device that provides rapid, comprehensive blood coagulation profiling at the point-of-care using a small drop of blood. The technology is based on laser speckle rheology and has been validated in clinical studies comparing its performance to established methods like thromboelastography. It enables timely detection of impaired coagulation and can guide transfusion decisions or anticoagulation therapy in various hospital settings. The product is not yet commercially launched but is undergoing further development and validation.

Therapeutic areas: CardiovascularHematology
Modalities: DeviceOptical sensor-based diagnostic platform
Industry: Physiological Monitoring

Partnerships

Massachusetts General Hospital (technology originator)

Beyond the preview

Go deeper on Coalesenz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coalesenz.

Explore the full profile